At close: 2:16:35 PM GMT+1
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
32,001.0000
70,836.0000
45,647.0000
117,827.0000
Total Liabilities Net Minority Interest
8,227.0000
10,354.0000
12,673.0000
7,072.0000
Total Equity Gross Minority Interest
23,774.0000
60,482.0000
32,974.0000
110,755.0000
Total Capitalization
23,774.0000
60,482.0000
32,974.0000
110,755.0000
Common Stock Equity
23,774.0000
60,482.0000
32,974.0000
110,755.0000
Net Tangible Assets
23,757.0000
60,465.0000
32,957.0000
110,738.0000
Working Capital
23,381.0000
17,151.0000
31,528.0000
108,787.0000
Invested Capital
23,774.0000
60,482.0000
32,974.0000
110,755.0000
Tangible Book Value
23,757.0000
60,465.0000
32,957.0000
110,738.0000
Share Issued
70,061.4900
57,842.7300
44,365.2650
44,365.2650
Ordinary Shares Number
70,061.4900
57,842.7300
44,365.2650
44,365.2650
12/31/2020 - 11/28/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BIOVIC-B.ST Biovica International AB (publ)
1.7000
-2.19%
ACE.ST Ascelia Pharma AB (publ)
3.0000
0.00%
FBLG FibroBiologics, Inc.
2.2500
+10.84%
ENLV Enlivex Therapeutics Ltd.
1.2400
+5.08%
CYBN Cybin Inc.
9.61
+3.11%
FATE Fate Therapeutics, Inc.
1.6800
+1.20%
ARQT Arcutis Biotherapeutics, Inc.
14.99
+6.24%
ZEAL.CO Zealand Pharma A/S
737.00
+1.24%
ABCL AbCellera Biologics Inc.
2.8500
+5.17%
BNTX BioNTech SE
113.08
+1.56%